Our Recommendations
- Посібник mhGAP з надання допомоги під час гуманітарних надзвичайних станів (2016)
- Руководство по осуществлению mhGAP (2018)
- Guía de intervención mhGAP para los trastornos mentales, neurológicos y por consumo de sustancias en el nivel de atención de salud no especializada Versión 2.0 (2017)
- mhGAP Intervention Guide Mental Health Gap Action Programme Version 2.0 for mental, neurological and substance use disorders in non-specialized health settings (2016)
- Групповая интерперсональная терапия (ипт) при депрессии (2018)
New Publications
- Formation des prestataires de soins de santé au Guide d’intervention humanitaire mhGAP(GIH-mhGAP) (2023)
- Formation des prestataires de soins de santé au Guide d’intervention humanitaire mhGAP(GIH-mhGAP) (2023)
- Formation des prestataires de soins de santé au Guide d’intervention humanitaire mhGAP(GIH-mhGAP) (2023)
- mhGAP Humanitarian Intervention Guide (mhGAP-HIG) training of health-care providers. Training manual (2022)
- Implementing the mental health Gap Action Programme intervention guide (2021)
Filter
104
Featured
Recommendations
30
New Publications
10
Language
Document type
No document type
71
Training Material
14
Manuals
12
Fact sheets
3
Guidelines
2
Studies & Reports
1
Resource Platforms
1
Countries / Regions
Ukraine
3
Syria
3
Nepal
2
Global
2
Eastern Europe
2
Russia
2
South Sudan
2
Kenya
1
Middle East and North Africa
1
Western and Central Europe
1
Authors & Publishers
Publication Years
Category
Neurology & Psychology
9
Training Manuals
3
Guidelines
2
Mental Health
2
Humanitarian Aid
1
Mobile Training Tools & Apps
1
Toolboxes
Mental Health GAP Action Programme
75
Training Supporting Material mhGAP
63
mhGAP Guides
29
Neurological Disorders
16
Depression
15
Mental Disorders
13
Children/Adolescents Mental Disorders
11
Mental disorders, others
11
Modules
11
Epilepsy
9
Schizophrenia
7
Substance Use Disorders & Addiction
6
Health & Refugee
5
others
5
Psychosocial Support
5
Psychosocial Support
5
Bipolar Affective Disorders
4
Substance Use Disorders, Others
3
Psychosocial Support
3
Alzheimer's Disease & Dementia
3
Training & Capacity Building
3
Best Practice Models
2
Psychosocial Support (MHPSS)
2
Mental Health
2
Mental Health Online Resources
2
Stress
2
MHPSS – Psychosocial Support
2
Epilepsy
2
Self-harm & Suicide
2
Neurological disorders, Others
2
Africa
1
Posttraumatic stress disorder Adults
1
Training Manuals
1
General Studies & Reports
1
Mental Health
1
Mental Health Guidelines
1
Women's Mental Health
1
Psychosocial Support
1
Psychosocial Support
1
Anxiety Disorders
1
MHPSS Guidelines
1
Q 1: Are antidepressants (Tricyclic Antidepressants (TCA) and Selective Serotonin Reuptake Inhibitors (SSRI)) better (more
effective than/as safe as) than treatment as usual (placebo) in adults with depressive episode/disorder?
Q 3: Is brief, structured psychological treatment in non-specialist health care settings better (more effective than/as safe as) than treatment as usual in people with depressive episode/disorder?
Q10: In individuals with psychotic disorders (including schizophrenia) and bipolar disorders are psychoeducation, family interventions and cognitive-behavioural therapy feasible and effective?
Q9: Antidepressant medicines in individuals with a depressive episode in bipolar disorder1Q9: In individuals presenting with a depressive episode in bipolar disorder, are antidepressant medicines effective and safe?
Q9. In adults and children with convulsive epilepsy in remission, when should treatment be discontinued?
Q3: Can febrile seizures (simple or complex) be managed at first or second level care by non-specialist health care providers in low and middle income country settings? What is the role of diagnostic tests in the management of febrile seizures by non-specialists in low and middle income settings? Fo...
Q5: What is the added advantage of doing an electroencephalography (EEG) in people with convulsive epilepsy in non- specialist settings in low and middle income countries?
Learning objectives
• Promote respect and dignity for people with self-harm/suicide.
• Know the common presentations of self-harm/suicide.
• Know the principles of assessment of self-harm/suicide.
• Know the management principles of self-harm/suicide.
• Perform an assessment for self-...
Q 4: Is behavioural activation better (more effective than/as safe as) than treatment as usual in adults with depressive episode/disorder?brief, structured psychological treatment in non-specialist health care settings better (more effective than/as safe as) than treatment as usual in people with de...
Q6: Is advice on physical activity better (more effective than/as safe as) than treatment as usual in adults with depressive episode/disorder with inactive lifestyles
Q3: In individuals with a first psychotic episode with full remission, how long should antipsychotic drug treatment be continued after remission in order to allow for the best outcomes?
Q1: In individuals with psychotic disorders (including schizophrenia), are antipsychotic drugs safe and effective?
Q6: In individuals with psychotic disorders (including schizophrenia) who require long term antipsychotic treatment, are anticholinergic medications more effective in preventing or reducing extrapyramidal side-effects and/or improving treatment adherence than placebo/treatment as usual?
Second-generation antipsychotic medications for psychotic disorders (including schizophrenia)
recommended
Q14. SCOPING QUESTION: In adults with psychotic disorders (including schizophrenia), what is the comparative effectiveness and safety of second-generation antipsychotic medications?
Q 10: In adults and children with epilepsy, which psychological interventions used as adjunctive therapies with antiepileptic drugs when compared to placebo/comparator produce benefits/harm in specified outcomes?
Q6: What is the added advantage of doing neuroimaging in people with convulsive epilepsy in non-specialist settings in low and middle income countries?
Q4: Can convulsive epilepsy be diagnosed at first level care by a non-specialist health care provider in low and middle income country settings?
What can you expect?
As a future facilitator your role will be to learn about the structure of mhGAP-IG, how to teach the materials and utilize opportunities to prastice facilitation and supervision skills.
As a supervisor your role will be to serve as a point of reference for non-specialized heal...
This module should always be used together with the
mhGAP Intervention Guide for Mental, Neurological
and Substance Use Disorders in Non-specialized Health
Settings (WHO, 2010), which outlines relevant general
principles of care and management of a range of other
mental, neurological and substa...
